0

Trimethoprim-Sulfamethoxazole

PMID: 30000348

Abstract:

With healthy, fullterm infants it appears acceptable to use sulfamethoxazole and trimethoprim during breastfeeding after the newborn period. The time of greatest risk for hemolysis in fullterm newborns without glucose-6-phosphate dehydrogenase (G6PD) deficiency might be as short as 8 days after birth.[1] Until further data are accumulated, alternate agents should probably be used in jaundiced, ill, stressed or premature infants, because of the risk of bilirubin displacement and kernicterus. Sulfamethoxazole and trimethoprim should be avoided while breastfeeding a G6PD-deficient infant.[2][3]

Chemicals Related in the Paper:

Catalog Number Product Name Structure CAS Number Price
AP119691757 Sulfamethoxazole N4-glucoside Sulfamethoxazole N4-glucoside 119691-75-7 Price
qrcode